AKT1 and hepatocellular carcinoma: For example, miR-30a-3p inhibits hepatocellular carcinoma cell proliferation via the PI3K/AKT signaling pathway by targeting DNMT3a [24] and suppresses renal cell carcinoma invasion and metastasis by targeting ATG12 [25].